Advanced pharmaceutical research laboratory

Excellence in Organic Synthesis & Life Sciences R&D

Connecting Science with Commerce

Translating intricate chemical innovation into reproducible pharmaceutical applications and empowering future industry leaders through comprehensive technical training.

Regulatory Inspection Expertise & Leadership (USFDA & EDQM)

Served as Key SME and Core Team Leader driving audit preparedness and regulatory defense during USFDA and EDQM inspections at Enaltec Labs, Emcure Pharmaceuticals, Amneal Pharmaceuticals, and FDC Limited.

Dr. Sudhir Sawant
Dr. Sudhir S. Sawant
Ph.D. Organic Chemistry
32+
Years in API Process R&D
45
API Molecules Validated
37+
USDMF / CEP Validations
9 · 16
International Patents · Peer reviewed Research Papers
Core Research & Process

Precision Route Design & Technology Transfer

Dr. Sudhir Sawant brings decades of synthesis leadership to pharmaceutical stakeholders, resolving high-friction reaction stages and ensuring regulatory concordance across global markets.

API Process Optimization

Redesigning complex reaction cascades to increase volumetric productivity and eliminate hazardous reagents during early development phases.

Scalability Engineering

Analytical Quality Control

Establishing stringent spectroscopic standards, method validation protocols, and impurity fate mapping to satisfy ICH guidelines and regulatory expectations.

Regulatory Assurances

Advisory

Strategic advisor and technical reviewer for the life sciences industry, CDMOs/CMOs, and academic institutions — driving excellence in generic drug development, IP strategy, and regulatory compliance.

Strategic Counsel
Proven Outcomes
₹75 lakhs / yr
Saved on the MXN process — CEP approved 2023
$300 / Kg
Cost reduction on Rupatadine Fumarate — CEP filed with EDQM
First Sterile API
Sterile, injectible, ophthalmic grade and Oncology APIs BXN process validation — a first in An Indian Pharma history
50+
Scientists led & mentored across R&D programmes
Dr. Sudhir Sawant in the laboratory
Credentials
  • Ph.D. in Organic Chemistry, University of Mumbai
  • M.Sc. Organic Chemistry, University of Pune
  • UGC-JRF/LS qualified, 1994
  • Board of Studies member, Dept. of Chemistry, L N Patkar College, Mumbai (since 2023)
  • Director, Rotary Club of Thane Premium (a NGO rendering social services)
About

Dr. Sudhir S. Sawant

Connecting Science with Commerce

A pharmaceutical R&D leader with more than 32 years across medicinal chemistry, API process development and technology transfer — from NCE research at Hoechst India & Nicholas Piramal to heading API Synthesis & Process Development for regulated markets at Sandoz, Emcure, GranulesOmniChem, Enaltec, Amneal and FDC Ltd.

His work spans the full arc from literature survey and route selection to validated, commercially viable processes: 45 API molecules taken through process validation, 37+ validations supporting USDMF/CEP regulatory filings, 9 published process patents and 16 research papers. Alongside the science, he has led teams of scientists and trained R&D, production and QA teams on QbD, safety practices, documentation and IPR.

Career Path
2026 - Present
Head of R&D, API Business (Senior GM)
Indian Pharma Organisation, Mumbai
2017 - 2026
Senior GM & Head, API Synthesis & Process Development
FDC India Ltd, Mumbai
2015 — 2017
Deputy GM, Synthesis & Process Development
Enaltec Labs, Navi Mumbai
2013 — 2015
Senior Manager, Process Development & Tech Transfer
GranulesOmniChem (now Ajinomoto Biopharma), Visakhapatnam
2010 — 2013
Senior Manager, Technology Transfer (API)
Emcure Pharmaceuticals, Pune
2004 — 2010
Senior Scientist, API Process Development
Sandoz Pvt Ltd., Thane
1994 — 2004
Scientific Officer to Scientist, NCE & Process Research
Hoechst India Ltd., Nicholas Piramal & Alkyl Amines
Scientific Record

Patents & Research Publications

Intellectual property and peer-reviewed research spanning three decades of process chemistry — 9 published process patents and 16 research papers in international journals.

Process Patents (9)

01
Method of preparing Lifitegrast via transesterification and the compound thereof
Indian Patent Application No. IN202421016176 · 07.03.2024
02
Terminal sterilisation of active pharmaceutical ingredients
Indian Patent Application No. 202121057381 · 09.12.2021 · Granted Indian Patent No. IN550748 · 23.09.2024
03
A process for obtaining pure Betaxolol
Indian Patent Provisional Application No. 201921010183 · 15.03.2019 · Granted Indian Patent No. IN463943 · 31.10.2023
04
Process for the preparation of 2-Amino-3-benzoyl-phenylacetyl derivatives and novel intermediates thereof
Indian Patent Provisional Application No. 201921002496 · 21.01.2019
05
Process for the preparation of Indoline derivatives and their intermediates thereof
PCT Application No. WO/2011/030356 · 17.03.2011
06
Processes for the synthesis of Bazedoxifene acetate and intermediates thereof
PCT Application No. WO 2010 118997 A1 · 09.04.2010 & US 2012 0253038 · 04.10.2013
07
A process for the preparation of aminoethoxybenzyl halides for the synthesis of Bazedoxifene acetate
Application No. 2291/MUM/2008 · 24.10.2008
08
A process for the preparation of 3-substituted-4-aryl piperidine compounds
Indian Patent Application No. 691/MUM/2006
09
Sertraline acid addition salt, its preparation and its use in the preparation of sertraline hydrochloride Form II
US 20070054960 A1

Selected Publications (13 of 16)

01
Novel alkylation-annulation reaction of Fischer carbene complexes
Organometallics, 1995, 14, 3617-3619
02
Preparation of Schiff base zinc metal complex (DMAPIMP)2Zn and development of HPLC chromatographic method for its analysis
J. Chem. Pharm. Res., 2011, 3(1), 188-198
03
Synthesis and characterization of novel transition metal complexes of benzo-a-pyranone derivatives and their biological activities
Asian J. Research Chem., 2011, 4(5), 834-837
04
An efficient synthesis of Rabeprazole sodium
Asian J. Pharm. Res., 2011, 1(1), 1-4
05
Dealing with the challenges during manufacturing of polymorphic drug substances
Asian J. Res. Pharm. Sci., 2011, 1(3), 63-68
06
Synthesis and characterization of novel impurities in Paroxetine hydrochloride hemihydrate and adopting QbD principles to build in quality in process of final drug substance
Asian J. Res. Chem., 2012, 5(3), 329-335
07
Synthesis, characterization and anti-tuberculosis activity of novel transition metal complexes of heterocyclic Schiff bases
Int. J. Advanced Research in Applied Chemistry, 2013
08
Developing a commercially viable process for an active pharmaceutical ingredient — challenges, myths and reality in the art of process chemistry
The Open Process Chemistry Journal, 2013, 5, 1-10
09
Novel Zinc(II) complexes as antimicrobial agents: synthesis, characterisation and antimicrobial studies
Bioinorganic Chemistry and Applications, Hindawi, 2014
10
Review: An update on drug discovery and natural products
Asian J. Pharmaceutical Science and Technology, 2015, 5(3), 137-155
11
In silico appraisal, synthesis, antibacterial screening and DNA cleavage for 1,2,5-thiadiazole derivative
Current Computer-Aided Drug Design, 2019, 15(5), 445-455
12
An Improved Commercial Process for the Preparation of Lifitegrast
Org. Process Res. Dev., 2024, 28(12), 4374-4379 · DOI: 10.1021/acs.oprd.4c00356
13
Determination and Quantification of a N-nitroso-Brinzolamide in the Brinzolamide Active Pharmaceutical Ingredient by LC-MS/MS
Acta Scientific Pharmaceutical Sciences, 2024, 8(12), 62-66 · DOI: 10.31080/ASPS.2024.08.1141
Professional Upskilling

Equipping Students for Pharmaceutical Careers

Designed specifically for pharma research and development students and emerging scientists, these masterclasses bridge textbook organic chemistry with modern industrial R&D. Delivered by a trainer who has run sessions on QbD, safety practices, documentation and IPR for R&D, production and QA teams.

Inquire for University Cohorts
1

Practical Reaction Troubleshooting

Systematic techniques for identifying conversion stalls, incomplete coupling, and side-product formation.

2

Modern Chromatography Operations

Stationary phase selection, gradient design, and quantitative purity assay validation in regulated settings.

3

Data Integrity & Electronic Lab Notebooks

Developing transparent documentation habits required by global health authorities and research audit teams.

Impact Validation

Industry & Student Endorsements

Awaiting First Endorsement

Written endorsements from academic institutions and industry collaborators will be published here, with their consent, as engagements conclude.

Published With Consent Only
Endorsement Portal

Institutional collaborations and graduate trainee reviews are published here as training cohorts conclude.

Continuous Academic Assessment
Connect Online

Initiate Collaboration with Dr. Sawant

Available worldwide for online consultations, technical virtual audits, lecture series, and specialized pharmaceutical training programs.